Treatment considerations for vulnerable patients with pemphigus during the COVID-19 pandemic are outlined.
All articles by Dibash Kumar Das, PhD
During the COVID-19 pandemic, there will be more of a reliance on expert guidance and less on evidence-based medicine when determining treatment protocols.
Cancer incidence in children with atopic dermatitis treated with topical tacrolimus was as expected in a study examining their possible relationship.
Patients with rosacea possess serum bilirubin and uric acid levels that differ from those found in healthy patients, a novel study finds.
The delayed onset of a severe cutaneous reaction to hydroxychloroquine means clinicians may continue to see patients presenting with the symptoms.
Is there an advantage to treating children who have pigmented purpuric dermatoses with vitamin C and rutoside vs watchful waiting?
Treatment of acne scarring with low-energy double-pass 1450-nm diode laser garners satisfaction from patients.
In this review, an investigator highlights the latest results of immune checkpoint inhibitors (ICI) for the treatment of locally advanced and metastatic cutaneous squamous-cell carcinoma.
Treatment guidelines are provided and vigilance recommended by the European Task Force on Atopic Dermatitis.
The lower rate of severe COVID-19 infection in women and children may be because of their lower androgen receptor expression.
Volume freezing limitations of a single needle were shown in a novel, reproducible biophysical model for studies on intralesional cryosurgery of keloids.
The guideline provides current, evidence-based recommendations on the use of biologic therapies in adults, children, and young people for the treatment of psoriasis.
Screening for severe mental illness during the assessment of patients with HS is vital, as comorbid psychiatric disorders may influence outcomes and a psychodermatology consolation may be necessary.
There appears to be much racial and ethnic disparity in global atopic dermatitis clinical trials despite the disease’s prevalence in developed nations.